Ligand Pharmaceuticals Inc (LGND)

Change in Working Capital

-$7.00M

Quarterly · Period ending: · USD

LGND logo

LGND Change in Working Capital

Latest reported-$7.00M
LGND Quarterly Change in Working Capital ($2.10M → -$7.00M)
High-resolution chart · PNG

LGND change in working capital history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Change in Working Capital — Quarterly (USD)
Period endingChange in Working Capital (USD)
9,070,000
-5,988,000
13,597,000
-5,033,000
3,674,000
-4,497,000
300,000
12,100,000
1,500,000
-10,500,000
6,700,000
-3,800,000
3,900,000
-8,300,000
13,400,000
-1,000,000
100,000
-400,000
3,000,000
-3,900,000
-200,000
-2,900,000
2,400,000
300,000
-600,000
900,000
800,000
2,100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.